Gout: When Infusion Therapy Becomes an Option
Most gout is managed with oral medication. But for a smaller group of patients whose gout doesn't respond to standard treatment, an infusion therapy can bring uric acid levels under control.
What is gout?
Gout is a form of inflammatory arthritis caused by a buildup of uric acid in the blood. When uric acid levels stay too high for too long, sharp, needle-like crystals can form in and around the joints, most classically the big toe, though gout can affect ankles, knees, wrists, and fingers too. A gout flare typically comes on fast: sudden, intense pain, swelling, redness, and warmth in the joint, often overnight.
Most people manage gout with lifestyle changes and oral medications that either reduce uric acid production or help the kidneys clear it more efficiently. For most patients, that's enough to keep flares infrequent and joint damage from progressing.
When gout becomes "refractory"
A smaller subset of patients continue to have frequent flares, persistent joint pain, or visible uric acid deposits (called tophi) even after trying multiple standard oral medications at appropriate doses. This is referred to as chronic refractory gout, and it's where infusion therapy comes in.
Krystexxa (pegloticase) is the infusion therapy used for chronic gout that hasn't responded to conventional treatment. It works differently than oral gout medications: it's an enzyme therapy that breaks uric acid down directly into a substance the body can clear easily, rather than just slowing production. In clinical trials, it lowered uric acid to target levels in a meaningful share of patients who had not responded to anything else.
What to expect during an infusion visit
Krystexxa is typically given as an IV infusion once every two weeks, often alongside methotrexate, which research has shown improves how well the treatment works and how long it lasts. Because allergic reactions are a real risk with this medication, and can happen quickly, usually within the first couple hours of infusion, you'll be premedicated beforehand and monitored closely by clinical staff throughout the visit and for a period afterward.
It's also common to experience more frequent gout flares in the first few months of treatment, even as the medication is working. This happens as crystal deposits that built up over time begin to dissolve, and your care team will typically have you on flare-prevention medication during this period to manage it.
Most patients see meaningful improvement over six to twelve months of consistent treatment, though response varies and is tracked with regular uric acid blood tests.
Why physician oversight matters
Because of the infusion reaction risk and the need to actively manage flares during the early months of treatment, chronic refractory gout is one of the conditions where having a physician on site, not just on call, makes a real difference. Any reaction during infusion can be addressed immediately, and your treatment plan can be adjusted visit to visit based on how you're responding.
Living with gout that won't respond to treatment?
Our physician-led team works directly with your rheumatologist to coordinate care, handle prior authorization, and make every visit as comfortable as possible.
Call (551) 336-5580See all conditions we treat at Specialty Infusions →
This article is for general educational purposes and is not a substitute for medical advice. Treatment decisions should always be made with your physician based on your individual diagnosis and health history.